Cullin 4A/protein arginine methyltransferase 5 (CUL4A/PRMT5) promotes cell malignant phenotypes and tumor growth in nasopharyngeal carcinoma

Targeted therapy is an important therapeutic strategy currently, however, the development of targeted therapy for nasopharyngeal carcinoma (NPC) is relatively lagging. Cullin 4A (CUL4A) was reported to be overexpressed in NPC; nevertheless, the specific role of CUL4A remains unrevealed. NPC cells an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiuying, Zhou, Jinhui, Zhang, Zhicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161857/
https://www.ncbi.nlm.nih.gov/pubmed/35333690
http://dx.doi.org/10.1080/21655979.2022.2054756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161857/
https://www.ncbi.nlm.nih.gov/pubmed/35333690
http://dx.doi.org/10.1080/21655979.2022.2054756

Ejemplares similares